Fresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns
Fresenius Medical Care is recalling specific lots of DELFLEX Peritoneal Dialysis Solution due to potential leaks in the primary bag that may compromise sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II due to a lack of assurance of sterility in an intraperitoneal dialysis solution, which presents a risk of serious adverse health consequences. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Fresenius Medical Care Renal Therapies Group, LLC is recalling 116 cases (5 bags per case) of DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium/Low Calcium. The affected product is identified by Lot 25NGPD001 and an expiration date of 4/30/2027. The product is distributed nationwide in the USA.
The recall was initiated because complaints were received regarding potential leaks from small perforations in the print area on the primary bag. These defects may result in a lack of assurance of sterility for the intraperitoneal solution.
Patients and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product is found, it should be stopped and returned to the supplier or the manufacturer.
The recalled product
- Product
- DELFLEX (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE)
- Brand
- DELFLEX
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 25NGPD001
- Exp 4/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DELFLEX
- SevereFresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- SevereFresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- SevereFresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- SevereFresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- HighPeritoneal Dialysis Solution Recalled for Tube Weld Failure Risk
FDA (Drugs) · 2024-07-24
Same manufacturer · Fresenius Medical Care Renal Therapies Group, LLC
See all →- ModerateFresenius CombiSet Hemodialysis Blood Tubing Set Recalled for Handling Review
FDA (Devices) · 2026-09-30
- ModerateFresenius Citrasate Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
- ModerateFresenius NaturaLyte Liquid Acid Concentrate Recalled for Discoloration
FDA (Devices) · 2026-09-09
Same hazard · sterility
See all →- SeverePreferred Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- SevereEagle Pharma Recalls Phenylephrine Infusion Due to Sterility Concerns
FDA (Drugs) · 2026-11-04
- SevereEagle Pharma Recalls Oxytocin Injection Due to Sterility Concerns
FDA (Drugs) · 2026-11-04
- SevereFDA Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-28
- SevereHeparin Sodium Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-28
Similar recalls
- SevereFresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Sterility Concerns
FDA (Drugs) · 2026-11-11
- HighFresenius Recalls DELFLEX Peritoneal Dialysis Solution Due to Bag Leakage
FDA (Drugs) · 2018-03-28
- HighPeritoneal Dialysis Solution Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2024-01-10
- SevereDELFLEX Peritoneal Dialysis Solution Recall Due to Potential Sterility Issues
FDA (Drugs) · 2026-05-13
- ModerateDELFLEX Peritoneal Dialysis Solution Recalled for Temperature Abuse
FDA (Drugs) · 2021-06-16
- HighDELFLEX Peritoneal Dialysis Solution bags recalled for sterility risk
FDA (Drugs) · 2026-05-13